Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. (IMDX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · IMDX · as of Jun 9, 2026
Activity summary
Buy transactions
14
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Insight Molecular Diagnostics Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
IMDX insider buying and selling by quarter
IMDX insider selling · IMDX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · IMDX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
IMDX executive sell shares · IMDX board member insider trading · IMDX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 26, 2026 | James Andrea S. CFO | Option | 28,302 | — | Form 4 |
| Mar 26, 2026 | James Andrea S. CFO | Other | 11,298 | $46K | Form 4 |
| Mar 26, 2026 | Liu James Yang VP ACCT, Cntlr, Treasurer, PAO | Option | 6,289 | — | Form 4 |
| Mar 26, 2026 | Liu James Yang VP ACCT, Cntlr, Treasurer, PAO | Other | 2,578 | $11K | Form 4 |
| Mar 26, 2026 | Riggs Josh CEO and President · Director | Option | 47,170 | — | Form 4 |
| Mar 26, 2026 | Riggs Josh CEO and President · Director | Other | 12,310 | $51K | Form 4 |
| Oct 31, 2025 | James Andrea S. CFO | Option | 50,000 | — | Form 4 |
| Apr 5, 2023 | PURA VIDA INVESTMENTS, LLC 10 percent owner | Purchase | 663,000 | $200K | Form 4 |
Liu James Yang
VP ACCT, Cntlr, Treasurer, PAO
Date
Mar 26
Shares
6,289
Price
—
Value
—
Liu James Yang
VP ACCT, Cntlr, Treasurer, PAO
Date
Mar 26
Shares
2,578
Price
$4.11
Value
$11K
Riggs Josh
CEO and President · Director
Date
Mar 26
Shares
47,170
Price
—
Value
—
Riggs Josh
CEO and President · Director
Date
Mar 26
Shares
12,310
Price
$4.11
Value
$51K
PURA VIDA INVESTMENTS, LLC
10 percent owner
Date
Apr 5
Shares
663,000
Price
$0.30
Value
$200K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About IMDX insider trading
IMDX insider trades
Insight Molecular Diagnostics Inc. (IMDX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including James Andrea S. (CFO), Liu James Yang (VP ACCT, Cntlr, Treasurer, PAO), Riggs Josh (CEO and President · Director). Over the past 12 months, 3 insiders have filed transactions with the SEC. IMDX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Insight Molecular Diagnostics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
IMDX insider trading · 5 questionsThe insiders of Insight Molecular Diagnostics Inc. (IMDX) include executives and directors such as James Andrea S. (CFO), Liu James Yang (VP ACCT, Cntlr, Treasurer, PAO), Riggs Josh (CEO and President · Director), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026